{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:31:22Z","timestamp":1786998682837,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2024ZDXM004"],"award-info":[{"award-number":["2024ZDXM004"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"DOI":"10.1007\/s10278-025-01782-2","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T18:30:13Z","timestamp":1765305013000},"page":"3260-3275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Precision Risk Stratification in Prostate Cancer: Unveiling MRI-Based Habitat-Driven Radiomics Model for Enhanced Treatment Guidance"],"prefix":"10.1007","volume":"39","author":[{"given":"Yang","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"1782_CR1","doi-asserted-by":"publisher","unstructured":"Swanton, Charles.Intratumor Heterogeneity: Evolution through Space and Time.CANCER RESEARCH, https:\/\/doi.org\/10.1158\/0008-5472, Oct 1, 2012","DOI":"10.1158\/0008-5472"},{"key":"1782_CR2","doi-asserted-by":"publisher","unstructured":"Yochai W, Yardena S. Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally. Clin Cancer Res, https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1355, Jul 15, 2022","DOI":"10.1158\/1078-0432.CCR-21-1355"},{"key":"1782_CR3","doi-asserted-by":"publisher","unstructured":"Nicholas M, Charles S. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell, https:\/\/doi.org\/10.1016\/j.cell.2017.01.018, Feb 9, 2017","DOI":"10.1016\/j.cell.2017.01.018"},{"key":"1782_CR4","doi-asserted-by":"publisher","unstructured":"Robert J G, Joel S B, Alexander R A A, Robert A G. Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow. Nat Rev Cancer, https:\/\/doi.org\/10.1038\/s41568-018-0030-7, Sep, 2018","DOI":"10.1038\/s41568-018-0030-7"},{"key":"1782_CR5","doi-asserted-by":"publisher","unstructured":"Michele DP, Daniela B, Tatiana V P. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer 2017, https:\/\/doi.org\/10.1038\/nrc.2017.51, Jul 14,2017","DOI":"10.1038\/nrc.2017.51"},{"key":"1782_CR6","doi-asserted-by":"publisher","unstructured":"Laura I C-N, Daniel M, Rachel A R, David F W, Siqing S, Mark W D. The pervasive presence of fluctuating oxygenation in tumors. Cancer Res 2008, https:\/\/doi.org\/10.1158\/0008-5472, Jul 15, 2008","DOI":"10.1158\/0008-5472"},{"key":"1782_CR7","doi-asserted-by":"publisher","unstructured":"Ibiayi D-J, Alice T S. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 2017, https:\/\/doi.org\/10.1038\/nrclinonc, Nov 8, 2017","DOI":"10.1038\/nrclinonc"},{"key":"1782_CR8","doi-asserted-by":"publisher","unstructured":"Melissa R J, Frederic J dS. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013, https:\/\/doi.org\/10.1038\/nature12626, Sep 19, 2013","DOI":"10.1038\/nature12626"},{"key":"1782_CR9","doi-asserted-by":"publisher","unstructured":"Xuanyi W, Tiansong X, Jurui L, Zhengrong Z, Xiaoli Y, Xiaomao G. Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res 2022, https:\/\/doi.org\/10.1186\/s13058-022-01516-0, Mar 15, 2022","DOI":"10.1186\/s13058-022-01516-0"},{"key":"1782_CR10","doi-asserted-by":"publisher","unstructured":"Yang Q, Yun-Fan L, Xin S, Xiao-Feng Q, Guang-Yong A, Xiao-Jing H. Peritumoral Radiomics Strategy Based on Ensemble Learning for the Prediction of Gleason Grade Group of Prostate Cancer. Acad Radiol , https:\/\/doi.org\/10.1016\/j.acra.2023.06.011, Jun 29,2023","DOI":"10.1016\/j.acra.2023.06.011"},{"key":"1782_CR11","doi-asserted-by":"publisher","unstructured":"Ji Eun P, Seo Young P, Hwa Jung K, Ho Sung K. Reproducibility and Generalizability in Radiomics Modeling: Possible Strategies in Radiologic and Statistical Perspectives. Korean J Radiol, https:\/\/doi.org\/10.3348\/kjr.2018.0070, Jul,2019","DOI":"10.3348\/kjr.2018.0070"},{"key":"1782_CR12","doi-asserted-by":"publisher","unstructured":"Kaustav B, Nathaniel B, Amit G, Vamsidhar V, Anant M. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol, https:\/\/doi.org\/10.1038\/s41571-021-00560-7, Oct 18, 2021","DOI":"10.1038\/s41571-021-00560-7"},{"key":"1782_CR13","doi-asserted-by":"publisher","unstructured":"Robert A G, Olya G., Robert J G. Quantitative imaging in cancer evolution and ecology. Radiology, https:\/\/doi.org\/10.1148\/radiol.13122697, Oct,2013","DOI":"10.1148\/radiol.13122697"},{"key":"1782_CR14","doi-asserted-by":"publisher","unstructured":"Ji Eun P, Ho Sung K, NakYoung K, Seo Young P, Young-Hoon K, Jeong Hoon K. Spatiotemporal Heterogeneity in Multiparametric Physiologic MRI Is Associated with Patient Outcomes in IDH-Wildtype Glioblastoma. Clin Cancer Res, https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2156, Jan 1, 2021","DOI":"10.1158\/1078-0432.CCR-20-2156"},{"key":"1782_CR15","doi-asserted-by":"publisher","unstructured":"Zhenwei S, Xiaomei H, Ziliang C, Zeyan X, Huan L, Chen L, et al. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology, https:\/\/doi.org\/10.1148\/radiol 222830,2023","DOI":"10.1148\/radiol"},{"key":"1782_CR16","doi-asserted-by":"publisher","unstructured":"Ruchika V, Ramon C, Virginia B H, Volodymyr S, Kaustav B, Niha B, et al. Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study. Radiol Artif Intell, https:\/\/doi.org\/10.1148\/ryai.2020190168, Nov 11, 2020","DOI":"10.1148\/ryai.2020190168"},{"key":"1782_CR17","doi-asserted-by":"publisher","unstructured":"Hwan-Ho C, Haejung K, Sang Yu N, Jeong Eon L, Boo-Kyung H, Eun Young K, et al. Measurement of Perfusion Heterogeneity within Tumor Habitats on Magnetic Resonance Imaging and Its Association with Prognosis in Breast Cancer Patients. Cancers (Basel), https:\/\/doi.org\/10.3390\/cancers14081858, Apr 7, 2022","DOI":"10.3390\/cancers14081858"},{"key":"1782_CR18","doi-asserted-by":"publisher","unstructured":"Nestor Andres P, Alan P, Felix M C, Matthew C A, Brian M, Felipe M, et al. Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness. Front Oncol , https:\/\/doi.org\/10.3389\/fonc.2017.00259, Nov 10, 2017","DOI":"10.3389\/fonc.2017.00259"},{"key":"1782_CR19","doi-asserted-by":"publisher","unstructured":"Radka S, Felix C, Deukwoo K, Isildinha M R, Yohann T, Nestor A P, et al. An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes. Int J Radiat Oncol Biol Phys, https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.003, Jun 13, 2018","DOI":"10.1016\/j.ijrobp.2018.06.003"},{"key":"1782_CR20","doi-asserted-by":"publisher","unstructured":"Nicolas M, Joaquim B, Michel B, Erik B, Marcus G C, Maria DS, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol, https:\/\/doi.org\/10.1016\/j.eururo.2016.08.003, Apr,2017","DOI":"10.1016\/j.eururo.2016.08.003"},{"key":"1782_CR21","doi-asserted-by":"publisher","unstructured":"Bimal B, R Jeffrey K, Laureano J R, Ross J M, Matthew T G, Igor F, et al. Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification. J Urol, https:\/\/doi.org\/10.1016\/j.juro.2017.06.085, Dec,2017","DOI":"10.1016\/j.juro.2017.06.085"},{"key":"1782_CR22","doi-asserted-by":"publisher","unstructured":"Xin S, Yunfan L, Xiaofeng Q, Guangyong A, Li L, Jun L, et al. Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification. Br J Radiol , https:\/\/doi.org\/10.1259\/bjr.20220238, Mar,2023","DOI":"10.1259\/bjr.20220238"},{"key":"1782_CR23","doi-asserted-by":"publisher","unstructured":"Ahmad A, Rakesh S, Shivani P, Andrei P, Sadhna V, Daniel M, et al. Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study. Cancers (Basel), https:\/\/doi.org\/10.3390\/cancers12082200, Aug 6, 2020","DOI":"10.3390\/cancers12082200"},{"key":"1782_CR24","doi-asserted-by":"publisher","unstructured":"\u00c1ngel SI, Virginia MM, Alfonso PP, Almudena F-M, Anna NI, Rodrigo MS, et al. Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction. Cancers (Basel), https:\/\/doi.org\/10.3390\/cancers15164163, Aug 18, 2023","DOI":"10.3390\/cancers15164163"},{"key":"1782_CR25","doi-asserted-by":"publisher","unstructured":"Simpa S S, Eran B-L, Oksana Y, Baris T, Robert V, Ardeshir R R. Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI. J Magn Reson Imaging, DOI, https:\/\/doi.org\/10.1002\/jmri.25363, Feb,2017","DOI":"10.1002\/jmri.25363"},{"key":"1782_CR26","doi-asserted-by":"publisher","unstructured":"Congying X, Pengfei Y, Xuebang Z, Lei X, Xiaoju W, Xiadong L, et al. Sub-region-based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy. EBioMedicine, https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.023, May 23,2019d","DOI":"10.1016\/j.ebiom.2019.05.023"},{"key":"1782_CR27","doi-asserted-by":"publisher","unstructured":"Karin E dV, Johanna A J. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell, https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016, Mar 13, 2023","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"1782_CR28","doi-asserted-by":"publisher","unstructured":"James P B OC, Chris J R, John C W, Richard A D C, Geoff J M P, Alan J. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res, https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0990, Nov 24, 2014","DOI":"10.1158\/1078-0432.CCR-14-0990"},{"key":"1782_CR29","unstructured":"Robert A G, Ariosto S S, Robert J G, B Roy F. Adaptive therapy. Cancer Res 2009;69"},{"key":"1782_CR30","unstructured":"Hamberg LM, Kristjansen PE, Hunter GJ, Wolf GL, Jain RK. Spatial heterogeneity in tumor perfusion measured with functional computed tomography at 0.05 microliter resolution. Cancer Res. , Dec 1, 1994"},{"key":"1782_CR31","doi-asserted-by":"publisher","unstructured":"Johnson PM, Dutt T, Ginocchio LA, Saimbhi AS, Umapathy L, Block KT, Sodickson DK, Chopra S, Tong A, Chandarana H. Prostate Cancer Risk Stratification and Scan Tailoring Using Deep Learning on Abbreviated Prostate MRI. J Magn Reson Imaging,https:\/\/doi.org\/10.1002\/jmri.29798, Apr 22, 2025.","DOI":"10.1002\/jmri.29798"},{"key":"1782_CR32","doi-asserted-by":"publisher","unstructured":"Rodrigues NM, Almeida JG, Rodrigues A, Vanneschi L, Matos C, Lisitskaya MV, Uysal A, Silva S, Papanikolaou N. Deep Learning Features Can Improve Radiomics-Based Prostate Cancer Aggressiveness Prediction. JCO Clin Cancer Inform. https:\/\/doi.org\/10.1200\/CCI.23.00180, Sep,2024","DOI":"10.1200\/CCI.23.00180"},{"key":"1782_CR33","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhao H, Lyu Z, Zhang L, Han W, Wang Z, Wang J, Zhang X, Guo S, Fu P, Zhao C. The value of habitat analysis based on 18F-PSMA-1007 PET\/CT images for prostate cancer risk grading. BMC Med Imaging. https:\/\/doi.org\/10.1186\/s12880-025-01829-4, Jul 21,2025","DOI":"10.1186\/s12880-025-01829-4"},{"key":"1782_CR34","doi-asserted-by":"publisher","unstructured":"Deanna L L, Theodorus H vdK, Andrew J E, Anna P, John T, Brian C W, et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology, https:\/\/doi.org\/10.1148\/radiol.10091343, May,2010","DOI":"10.1148\/radiol.10091343"},{"key":"1782_CR35","doi-asserted-by":"publisher","unstructured":"D G M, D L Jr B, S V, M D R. The biophysical basis of tissue contrast in extracranial MR imaging. AJR Am J Roentgenol, https:\/\/doi.org\/10.2214\/ajr.149.4.831, Oct,1987","DOI":"10.2214\/ajr.149.4.831"}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-025-01782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-025-01782-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-025-01782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:32:59Z","timestamp":1786995179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-025-01782-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1782"],"URL":"https:\/\/doi.org\/10.1007\/s10278-025-01782-2","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University, and the requirement for written informed consent was waived (No. [2019]289).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript declare relationships with the following companies: GE Healthcare. One of our authors is an employee of GE Healthcare. This author only provided technical support and did not have control over the data at any point during the study.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}